North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

announcing plans to build a $4.1 billion fill-and-finish facility for injectables in North Carolina, US. The new plant will be one of the largest manufacturing investments in Novo Nordisk’s ...

(Bloomberg) -- Novo Nordisk A/S was cited for quality ... Novo’s other site that makes semaglutide is in North Carolina. That ...

Novo Nordisk announced a $4.1 bn (€3.74bn) investment in June this year, to expand its US manufacturing capacity with a new ...

IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...